p53 overexpression in advanced-stage endometrial adenocarcinoma
- 30 November 1996
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 175 (5), 1246-1252
- https://doi.org/10.1016/s0002-9378(96)70036-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Molecular basis of endometrial cancerCancer, 1995
- Clinicopathological characteristics of p53 overexpression in endometrial cancersInternational Journal of Cancer, 1994
- Multivariable analysis of DNA ploidy, p53, and HER-2/neu as prognostic factors in endometrial cancerCancer, 1994
- The p53 tumor suppressor gene frequently is altered in gynecologic cancersAmerican Journal of Obstetrics and Gynecology, 1994
- Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian CancerJNCI Journal of the National Cancer Institute, 1993
- p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.Journal of Histochemistry & Cytochemistry, 1992
- A collaborative study of differences in the survival rates of black patients and white patients with cancerCancer, 1992
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991
- A Confidence Interval for the Median Survival TimeBiometrics, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958